Silence Therapeutics PLC (SLN) — SEC Filings
Silence Therapeutics PLC (SLN) — 1 SEC filings. Latest: 8-K (May 7, 2026). Includes 1 8-K.
View Silence Therapeutics PLC on SEC EDGAR
Overview
Silence Therapeutics PLC (SLN) is a publicly traded company with 1 SEC filings tracked on ReadTheFiling.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Silence Therapeutics PLC is neutral.
Filing Type Overview
Silence Therapeutics PLC (SLN) has filed 1 8-K with the SEC between May 2026.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| May 7, 2026 | 8-K | 8-K Filing |
Frequently Asked Questions
What are the latest SEC filings for Silence Therapeutics PLC (SLN)?
Silence Therapeutics PLC has 1 recent SEC filings from May 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SLN filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Silence Therapeutics PLC SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Silence Therapeutics PLC (SLN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Silence Therapeutics PLC?
Financial highlights for Silence Therapeutics PLC are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for SLN?
Investment thesis data for SLN will be available once enriched filings are processed.
Who are the key executives at Silence Therapeutics PLC?
Executive information for Silence Therapeutics PLC is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Silence Therapeutics PLC stock?
Risk factor analysis for Silence Therapeutics PLC is available when filings are enriched with AI risk assessment.
What are recent predictions and forward guidance from Silence Therapeutics PLC?
Forward guidance and predictions for Silence Therapeutics PLC are extracted from SEC filings as they are enriched.